Two Sigma Advisers’s CASI Pharmaceuticals CASI Stock Holding History

Two Sigma Advisers’s Portfolio CASI Stock Details CASI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-8,320	Closed	-$67K	–	2751
2021 Q4	$67K	Buy	+8,320	New	+$82.8K	﹤0.01%	2457
2021 Q3	–	Sell	-9,210	Closed	-$143K	–	2463
2021 Q2	$143K	Sell	9,210 -8,840	-49%	-$149K	﹤0.01%	2312
2021 Q1	$433K	Buy	18,050 +11,370	+170%	+$319K	﹤0.01%	2067
2020 Q4	$197K	Sell	6,680 -2,450	-27%	-$53.2K	﹤0.01%	2179
2020 Q3	$140K	Buy	+9,130	New	+$172K	﹤0.01%	2227

Other funds holding CASI

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WSCM

Wellington Shields Capital Management New York $788M AUM 66.95% 1-Year Est. Return

WSC

Wellington Shields & Co New York $446M AUM 38.92% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Two Sigma Advisers's CASI Position: Q1 2022 in Review

Two Sigma Advisers sold out of CASI Pharmaceuticals (CASI) in Q1 2022, closing a stake of 8,320 shares — an estimated $67K sold.

Two Sigma Advisers first reported a position in CASI in Q3 2020 and held it in 5 quarters. The position peaked at $433K in Q1 2021. 44 funds tracked by Wall St. Rank hold CASI as of Q1 2022.

Two Sigma Advisers reported no remaining CASI Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
Two Sigma Advisers sold 8,320 CASI Pharmaceuticals shares in Q1 2022, an estimated $67K.
Two Sigma Advisers first reported a position in CASI Pharmaceuticals in Q3 2020 and held it in 5 quarters.
Two Sigma Advisers's CASI Pharmaceuticals position peaked at $433K in Q1 2021.
44 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q1 2022.

Based on Two Sigma Advisers's 13F filing for Q1 2022, filed 16 May 2022.